LDN 2017 Conference Presentations to Focus on Autoimmune Diseases and Cancer
World experts in Portland share the latest Trials and Studies for Cancer at the LDN 2017 Conference.
PORTLAND, August 28, 2017 (Newswire.com) - The LDN 2017 Conference, the only dedicated Low Dose Naltrexone (LDN) conference in the world, will be held Sept. 22-24 at the Sheraton Portland Airport Hotel. The conference will feature 31 highly acclaimed speakers and will be livestreamed around the globe.
Dr. Akbar Khan, M.D. said, "The LDN conference is essential for medical professionals to attend. Through the dedicated research efforts of doctors around the world, LDN has been shown to be a powerful off-label therapy for the most prevalent and devastating chronic diseases including cancer and autoimmune conditions. Health professionals will not learn about LDN through traditional medical conferences because LDN is a generic low-cost drug. There is no motivation for the pharmaceutical industry to spend money educating doctors about this generic drug. Please attend! You will find this to be an exciting an eye-opening conference!"
Why Portland, Oregon? LDN is taught in medical schools in Portland which isn’t the norm, making it the ideal location.
Aim of the conference: to help educate MDs, DOs, NDs, PA-Cs, Nurse Practitioners and Pharmacists in the use of LDN and to encourage further trials and studies.
CE Credits from: The American Association of Naturopathic Physicians 26 Credits and The Oregon Board of Naturopathic Medicine 27.75 Credits.
About the LDN Research Trust: The LDN Research Trust is a UK Registered Charity, established in 2004. They have helped over 41,000 people in the U.S. to find an LDN Prescriber and actively help and support LDN Prescribers, Researchers and Pharmacists. www.ldnresearchtrust.org
Linda Elsegood and the speakers would be available for interview.
Press Passes are available upon request for the conference.
Source: LDN Research Trust